Literature DB >> 7684718

Type II autoimmune hepatitis. What is the role of the hepatitis C virus?

D Vergani, G Mieli-Vergani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7684718     DOI： 10.1016/0016-5085(93)90673-z

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  9 in total

Review 1.  Nonhepatic manifestations and combined diseases in HCV infection.

Authors:  S J Hadziyannis
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

2.  Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.

Authors:  R Klein; U M Zanger; T Berg; U Hopf; P A Berg
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 3.  Viral hepatitis.

Authors:  G V Gregorio; G Mieli-Vergani; A P Mowat
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

Review 4.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

5.  Lymphoblastoid interferon alfa treatment in chronic hepatitis C.

Authors:  R Iorio; P Pensati; S Porzio; I Fariello; S Guida; A Vegnente
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

6.  Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.

Authors:  L Muratori; M Lenzi; Y Ma; M Cataleta; G Mieli-Vergani; D Vergani; F B Bianchi
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

7.  Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia.

Authors:  M Peters; M Trippler; H Löhr; W Gödderz; W Herr; S Störkel; K H Meyer zum Büschenfelde; G Gerken
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

8.  Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.

Authors:  G V Gregorio; P Pensati; R Iorio; A Vegnente; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

Review 9.  In vitro analysis of metabolic predisposition to drug hypersensitivity reactions.

Authors:  R J Riley; J S Leeder
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.